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The Circular Bacteriocins Gassericin A and Circularin A
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Abstract: Gassericin A, a bacteriocin produced by Lactobacillus gasseri LA39, shows antibacterial activity against a
number of Gram-positive food-borne pathogenic bacteria. Circularin A produced by Clostridium beijerinckii ATCC25752
is active against C. tyrobutyricum , a known cheese-spoilage bacterium. Both bacteriocins were purified to homogeneity
from culture supernatants by reverse-phase chromatography and the subsequently determined amino acid sequences were
used to clone the bacteriocin structural genes. Mature gassericin A and circularin A are class V circular bacteriocins
comprised of 58 and 69 amino acid residues, respectively. Both bacteriocins are resistant to several peptidases and
proteases, as are other cyclic bacteriocins. Heterologous expression of gassericin A in Escherichia coli was used to
produce a non-cyclic mature peptide, which was shown to have a specific activity 173-fold lower than the circular
molecule. The minimal region for production and secretion of active circularin A is comprised of five genes, as was
deduced by heterologous gene expression in Enterococcus faecalis . Gassericin A and circularin A have limited mutual
similarity in their primary sequences. Unlike most bacteriocins, including gassericin A, circularin A has a three-amino-
acid-leader sequence.
INTRODUCTION
Bacteriocins are ribosomally synthesized anti-microbial
peptides, proteins or proteinaceous complexes produced by
bacteria that act mainly against closely related species.
Wide-spectrum bacteriocins could play an important role in
preventing the growth of harmful bacteria during the
fermentation and preservation of various foods such as meats
and dairy products [1, 2]. Bacteriocins from lactic acid
bacteria (LAB) have been most widely studied and have
been grouped into four classes I-IV [3, 4]. Lantibiotics are
peptides containing modified amino acid residues such as
lanthionine, ß-methyl lanthionine, and dehydrated residues
and belong to class I. Large proteins are part of class III,
while the least studied group (class IV), contains complex
molecules with lipids or carbohydrates. Class II contains
small and heat-stable peptides and has been divided into the
following categories: IIa, containing peptides with a
consensus sequence (YGNGVXAAC) in the N-terminal of
the mature bacteriocin; IIb, comprising peptides that require
the complementary action of another peptide(s); IIc, which
contains peptides that are secreted by the Sec-dependent
pathway.
Recently, a new class, class V, has been proposed: that of
the “cyclic bacteriocins” [5]. These peptides are
characterized by the fact that their N- and C-termini are
covalently linked. The first example of a cyclic bacteriocin
was enterocin AS-48, produced by Enterococcus faecalis
AS-48 (see review by Maqueda et al., in this volume).
Gassericin A, produced by Lactobacillus gasseri LA39 and
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circularin A, produced by Clostridium beijerinckii
ATCC25752, are further examples of this group of anti-
microbial peptides and will be discussed in this paper.
Strains of the Lactobacillus acidophilus group of
homofermentative LAB [6-8] are found in human and animal
intestines and are added as dietary adjuncts to commercial
fermented milk products, such as acidophilus yogurt,
because of their physiological functions as "probiotics": they
can survive and grow in the gastrointestinal tract [9]. The
intake of these bacteria may have beneficial effects on
human and animal health [9, 10]. There are a number of
reports on the production of bacteriocins by strains of the six
subgroups of L. acidophilus. L. johnsonii VPI11088 (lactacin
F) [11, 12], L. amylovorus LMG P-13139 (lactobin A) [13],
L. amylovorus DCE471 (amylovorin L471) [14] and L.
gasseri SBT2055 (gassericin T) [15] produce similar
bacteriocins. Lantibiotics have never been detected in strains
of L. acidophilus.
In contrast to LAB, which are used for food and feed
production, many species of clostridia are known as food-
spoilage bacteria [16], and as pathogens and toxin producers
[17]. Various clostridia produce bacteriocins such as BCN5
(Clostridium perfrigens) [18] and boticin B (C. botulinum)
[19]. Although bacteriocin production has been used in
clostridia strain typing [20,21], there have been only a few
studies on the molecular aspects of the regulation of
bacteriocin production and secretion by clostridia, let alone
on structure and function relationships.
In what follows we will review the literature on two
circular bacteriocins identified in two functionally differing
bacterial species, one a food-producer (L. gasseri), the other
a food-spoiler (C. beijerinckii), gassericin A and circularin
A, respectively.
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SELECTION AND PURIFICATION OF GASSERICIN
A, A BACTERIOCIN PRODUCED BY L. GASSERI
From 70 bacteriocin-producing Lactobacillus strains
isolated from human fecal specimens, the most widely
effective bacteriocin was gassericin A produced by L.
gasseri strain LA39 [22, 23]. Gassericin A showed
antibacterial activity against Gram-positive food-borne
pathogenic bacteria such as Listeria monocytogenes, Bacillus
cereus, and Staphylococcus aureus, but had no inhibitory
activity against Gram-negative microorganisms such as
Salmonella typhimurium, S. entritidis, and Escherichia coli
[24]. Gassericin A was purified to homogeneity from the
supernatant of a culture grown in a modified MRS broth by
reverse-phase chromatography [25, 26] and shown to have a
molecular weight of 5,652 by mass spectrometry. This
molecular weight was different from that estimated by SDS-
PAGE (3,800). The purified bacteriocin was highly
hydrophobic and did not dissolve in water.
SELECTION AND PURIFICATION OF CIRCULARIN
A, A BACTERIOCIN PRODUCED BY C.
BEIJERINCKII
From 12 clostridial strains tested, circularin A produced
by C. beijerinckii ATCC25752 was the most effective
bacteriocin against C. tyrobutyricum NIZOB570, a known
cheese-spoilage bacterium [5]. Circularin A was purified to
homogeneity from the supernatant of a culture grown in an
AC broth dialysate by reverse-phase HPLC and was shown
to have an apparent molecular weight of 2,200 by SDS-
PAGE. Circularin A showed antibacterial activity against C.
tyrobutyricum, E. faecalis, L. alimentarius, L. sake and
Lactococcus lactis [5].
GASSERICIN A: STRUCTURAL GENE AND AMINO
ACID SEQUENCE
After digestion of purified gassericin A with
lysylendopeptidase and subsequent determination of the N-
terminal amino acid sequence of the digestion product, the
structural gene of gassericin A was cloned by reverse
genetics. The gene, gaaA (DDBJ, EMBL, and GenBank
databases, accession number AB007043), was shown to
encode a protein of 91 amino acid residues with a calculated
molecular weight of 9,286 [26].
Purified gassericin A was digested by lysylendopeptidase
and 3-bromo-3-methyl-2-(2-nitrophenyl-mercapto)-3H-
indole, which cleaves the tryptophanyl bonds, and the
liberated peptides were sequenced by N-terminal protein
sequencing [27]. All amino acid residues of gassericin A
were identified in this way and the derived amino acid
sequence was the same as that deduced from the structural
gene gaaA. The molecular weight, 5,652 by mass-
spectrometry, of gassericin A conformed to the weight
expected after the elimination of H2O from the deduced
amino acid sequence. Mature gassericin A is a cyclic (class
V) bacteriocin of 58 amino acid residues, in which the N-
(Ile) and C-(Ala) terminal ends are covalently linked [27].
In silico analysis revealed that only two bacteriocins
showed considerable sequence similarity to gassericin A
(Fig. 1). One of these, acidocin B produced by L. acidophilus
M46, has 98% identity with the gassericin A precursor but
was not identified as a circular bacteriocin [28] (GenBank
accession number Z34920). The mature bacteriocins differ in
only one amino acid residue. Acidocin B has an apparent
molecular weight of 2,400 as measured by SDS-PAGE,
while the deduced molecular weight is 5,750. The other
molecule is butyrivibriocin AR10 produced by the ruminal
anaerobe Butyrivibrio fibrisolvens AR10 [29,30]. The cyclic
bacteriocin (GenBank accession number AF076529) has
45% identity with gassericin A. N- and C-terminal regions of
mature gassericin A before circularization have especially
high similarities with those predicted for butyrivibriocin
AR10. This would indicate that these regions are involved in
processing and cleavage to form the circular bacteriocins or
are important for bacteriocin activity.
CIRCULARIN A: STRUCTURAL GENE AND AMINO
ACID SEQUENCE
After cleavage of purified circularin A using cyanogen
bromide, which cleaves methionyl bonds, and subsequent
determination of the N-terminal amino acid sequence of the
cleavage products, the structural gene of circularin A was
cloned by reverse genetics [5]. The gene, cirA (GenBank
databases, accession number AY164463), was shown to
encode a protein of 72 amino acid residues. From the
internal amino acid sequences of peptide fragments of
circularin A and the amino acid sequence deduced from cirA,
circularin A was concluded to be a cyclic bacteriocin (class
Fig. (1). Comparison of the primary amino acid sequences of gassericin A (GA, mature), acidocin B (AB, putative) and butyrivibriocin
AR10 (BA, putative). Colons and periods show identical and homologous amino acids, respectively. The overlining indicates the
circularization point.
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V) that is covalently closed at N-(Val) and C-(Tyr) terminal
amino acid residues. Mature circularin A comprises 69
amino acid residues. A BLAST search revealed that
circularin A has 60% similarity (31% identity) with the
cyclic bacteriocin enterocin AS-48, which contains 70 amino
acids (Fig. 2). In contrast to the situation in gassericin A and
butyrivibriocin AR10, enterocin AS-48 and circularin A
have only limited mutual similarity.
HETEROLOGOUS EXPRESSION OF GASSERICIN A
AND CIRCULARIN A
Mature non-cyclic gassericin A was fused with a protein
tag and expressed in E. coli. The specific activity of purified
mature gassericin A, liberated from the fusion protein
through digestion with factor Xa, was deduced to be 173-
fold lower than that of purified native mature gassericin A
[31].
The minimal region for production and secretion of
active circularin A has been identified by heterologous
expression of various deletion variants of the cir operon in E.
faecalis. In this way, five genes were identified as minimally
required [32]. This strategy also pinpointed the genes
involved in circularin A immunity, namely cirE, the true
immunity gene, and the combination of cirB and cirD, which
together give additional resistance.
Secretion of LAB bacteriocins has been shown to
proceed in either of three ways: some bacteriocins are
secreted via the general sec-pathway of protein secretion, the
LsbA and LsbB bacteriocins of Lc. lactis are externalized via
multidrug resistance (MDR) proteins [33], while still other
bacteriocins are secreted via dedicated ABC-type
transporters, for which the genetic information is located in
the direct vicinity of the bacteriocin structural genes. Many
class II bacteriocins are released after being cleaved at a
conserved Gly-Gly motif at positions -2 and -1 in the
processing site by a proteolytically active domain in the C-
terminus of the dedicated secretion protein [34,35]. Although
their leader peptide sequences show similarities, the
sequences of the mature bacteriocins differ widely. ABC-
type transporter genes are found in the direct vicinity of the
structural genes of all known and putative circular
bacteriocins, suggesting that dedicated transporters are
involved in the secretion of these proteins, although none of
these transporters have been proven to be involved in
bacteriocin secretion as yet.
The putative leader peptide sequence of gassericin A
contains 33 amino acid residues and does not contain the
Gly-Gly motif. It is more similar to the leader sequence of
nisin (Fig. 3). The processing site of gassericin A, predicted
by the program SignalP V2.0
(http://www.cbs.dtu.dk/services/ SignalP/), was the same as
the actual site in gassericin A. A gene encoding a protein
with a putative ATP binding domain is located downstream
of gaaA, suggesting that it may be involved in the secretion
of gassericin A (data not published).
Fig. (2).  Comparison of the primary amino acid sequences of circularin A (CirA) and enterocin AS-48 (AS48). Identical and homologous
amino acids are indicated by colons and periods, respectively. Underlined amino acids: positions of the a-helices in the crystal structure of
bacteriocin AS-48 as measured in N-decyl-beta-D-maltoside [50]. The over and underlining show the circularization of the molecules.
Fig. (3). Comparison of the leader peptide sequences of gassericin A and circularin A with those of nisin, enterocin AS-48 and
butyrivibriocin AR10 (putative). The arrows show processing sites in mature bacteriocins (putative site in parenthesis). The hyphen was
added to give optimum alignment.
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In contrast, only 3 amino acids are cleaved from the
circularin A precursor to obtain an active, secreted circular
molecule [5]. This is quite different from enterocin AS-48, in
which the processing site is similar to that of gassericin A
and the putative site of butyrivibriocin AR10 (Fig. 3).
LIMITED PROTEOLYSIS OF CYCLIC BACTER-
IOCINS
Gassericin A (Fig. 4) and circularin A are quite resistant
to several peptidases and proteases [5,31], as are the other
cyclic bacteriocins, microcin J25 [36] and enterocin AS-48
[37]. The resistance of the latter bacteriocin might be due to
the compact globular structure of the molecule (see review
by Maqueda et al. , in this volume) and it could explain the
proteolytic stability of the other circular bacteriocins, if they
too have similar compact structures. In fact, non-cyclic
gassericin A purified from E. coli and cyclic gassericin A
both migrated as peptides with a molecular weight of 3,800
in SDS-PAGE despite the actual molecular weights of 5666
and 5,652, respectively. This discrepancy may be due to the
tertiary structure of the peptide.
REUTERICIN 6, A CYCLIC BACTERIOCIN
IDENTICAL TO GASSERICIN A
L. reuteri is a gas-forming, heterofermentative LAB [38]
and some strains are known antibiotic producers (e.g. of
reuterin [39] and reutericyclin [40]). In our laboratory of
Animal Products Chemistry, Toba et al. [41] detected
reutericin 6, a narrow-spectrum bacteriocin produced by L.
reuteri LA6 that also inhibits the growth of B. cereus [24].
Kabuki et al. [42] isolated reutericin 6 from Tween 80-free
MRS diffusate broth, as the molecule, like gassericin A [25],
showed strong affinity with Tween 80. Reutericin 6 was
purified to homogeneity and was shown by amino acid
sequence analysis to be a cyclic bacteriocin identical to
gassericin A [43]. Nevertheless, the activity spectra of partly
purified reutericin 6 and gassericin A do seem to differ
[24,41]. The bacteriocin structural gene is located on the
chromosome of L. reuteri LA6. Although this is the first
example of identical bacteriocins in strains of the L.
acidophilus group of LAB, identical bacteriocins have been
reported in different other LAB species such as pediocin
AcH in Pediococcus acidilactici and L. plantarum [44, 45]
and curvacin A-sakacin A in L. curvatus and L. sake [46,47].
It is highly possible, but impossible to prove, that the genes
were transferred between L. reuteri and L. gasseri, as both
strains were isolated within a 2-months interval from the
feces of the same human infant.
CONCLUDING REMARKS
The circular bacteriocins gassericin A and circularin A
have been purified, their amino acid sequences chemically
determined and the bacteriocin structural genes have been
cloned. Although we have started to learn about the genetics
involved in gassericin A and circularin A production, a lot
still needs to be examined:
1. Nothing is known about the mode of action of the two
bacteriocins.
2. The genes involved in circularin A immunity have been
identified [32]. We are currently examining which factors
are involved in determining the resistance to gassericin
A.
3. The genes and proteins involved in bacteriocin secretion
are unknown for either bacteriocin. What seems to be
clear is that neither is secreted via a Gly-Gly motif
dedicated secretory system. Pre-gassericin A has an
extended N-terminal leader that may be involved in the
secretion process. Circularin A is singular in the fact that
only 3 amino acid residues are cleaved off from the pre-
bacteriocin to form the active, secreted peptide. Whether
this cleavage is needed for secretion is not known at the
moment.
4. It could be that the information for circularization of
circularin A is, in fact, encoded within this 3-amino-acid
leader. The process of circularization, which signals in
the (pre-) bacteriocin are involved, which enzyme(s)
performs the closing of the molecule, the site at which
this process takes place and whether or not it is directly
coupled to the secretion process, are all questions that
need to be answered. The fact that we have the nucleotide
sequences of the structural genes and the surrounding
regions of gaaA and cirA and the possibility of doing
heterologous gene expression studies opens up avenues
to tackle these problems in the near future.
Fig. (4). A map of protease and peptidase cleavage sites in gassericin A. Theoretical cleavage sites are shown above the amino acid
sequence, actual cleavage sites (confirmed by N-terminal amino acid sequencing) are presented below the sequence. Between brackets: upon
incubation with the indicated enzyme gassericin A was found not to be cleaved. Chy: chymotrypsin, ArgEP: arginylendopeptidase, LysEP:
lysylendopeptidase, Try: trypsin, and V8-P: V8 protease cleavage sites. The dotted line shows the putative a -helical membrane-spanning
domain that could act on the cytoplasmatic membrane of sensitive cells. Overlining: circularization point.
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5. Another point that needs to be addressed is the 3D-
structure of the two bacteriocins. Enterocin AS-48 and
circularin A have similar hydrophobicity profiles, similar
isoelectric points, similar distribution of glycine residues
and putative secondary structures, in addition to (limited)
homology of primary sequences. This would indicate that
the 3D-structure of circularin A might resemble that of
enterocin AS-48. The determination of the 3D-structure
of gassericin A has met with the problem that the purified
bacteriocin does not dissolve in water.
Although the primary sequences of gassericin A and
reutericin 6 are the same, the partly purified bacteriocins
appear to have different anti-microbial spectra. Although we
(Y. K. and T. S.) cannot at this stage exclude the presence of
other anti-microbial components in the bacteriocin
preparations, we are also examining the possibility that the
difference is caused by distinguished post-translational
modification mechanisms in the two producers (eg. D-/L-
amino acid conversions) [48].
Circularin A is produced by C. beijerinckii and works
effectively against clostridial strains. Although the mode of
action and safety of circularin A remain to be examined, as
well as the performance of the bacteriocin in food matrices,
this anti-microbial peptide could possibly be used to prevent
food spoilage by Clostridia. As L. gasseri is present as a
natural inhabitant of the human intestine, the bacteriocin and
the producer strain, as a probiotic, may be used safely and to
the benefit of human health [49]. Many strains of L. gasseri
only grow in expensive synthetic broths while only a few
strains grow in milk-based media. The development of
natural and low-cost broths for growth of L. gasseri may in
the near future provide opportunities for more varied
applications of the gassericin A producer, such as in
treatment of bovine mastitis and in fermented milk products
for human consumption.
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